Medications

First generic of symbicort receives FDA approval

The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol to treat asthma in patients 6 years and older and for maintenance treatment in ...

Diseases, Conditions, Syndromes

Your nose may know more when it comes to COVID-19

A University of Cincinnati ear, nose and throat specialist says your nose may hold a clue in identifying COVID-19. The loss of smell may be a key indicator.

Health

Breathing new life into respiratory support

New research from Massey University's College of Health has shed light on how an emerging therapy for respiratory support works—something that could benefit patients with obstructive sleep apnoea, chronic obstructive pulmonary ...

Surgery

Health utility values improve after septorhinoplasty

(HealthDay)—Patients with nasal airway obstruction have health utility values (HUVs) below the mean Australian norm, with improvement noted after open septorhinoplasty, according to a study published online Nov. 15 in JAMA ...

Immunology

Allergic rhinitis has negative impact on QOL in teens

(HealthDay)—For adolescents, allergic rhinitis (AR) has a negative impact, affecting quality of life, daily functioning, and sleep, according to a review published online recently in the Annals of Allergy, Asthma & Immunology.

Surgery

Full-length inferior turbinate reduction best improves airflow

(HealthDay)—The effectiveness of partial inferior turbinate reduction (ITR) for the treatment of nasal obstruction may depend on individual patient anatomy, according to a study published online Jan. 25 in JAMA Facial Plastic ...

Surgery

System collects data on functional septorhinoplasty

(HealthDay)—A system has been implemented that enables collection of pre- and postoperative data for patients with nasal obstruction who undergo functional septorhinoplasty, according to a special communication published ...

page 1 from 3